Tizanidine Tablet
Product Images NDC 80425-0436

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 80425-0436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine 2mg #30 (Tizanidine 2mg 80425 0436 01)

This is a description of a packed batch of 30 tablets of Tizanidine 2mg, a muscle relaxant medication under the brand name Zanaflex. The tablets should be stored at a temperature between 20°C to 25°C (68° to 77°F) and have an expiration date of September 30, 2025. The source NDC number is 72578-0096-10 and the lot number is X000.*

FDA Label Image

Tizanidine 2mg #60 (Tizanidine 2mg 80425 0436 02)

This is a description of a medication called Tizanidine 2mg Tablet. It comes in a bottle of 60 tablets and is compared to Zanaflex. The medication should be stored at a temperature range of 20-25°C (68-77°F). The NDC (National Drug Code) for this product is 80425-0436-02, with a source NDC of 72578-0096-10. The lot number is XO000OK and the expiration date is 9/30/2025.*

FDA Label Image

Tizanidine 2mg #90 (Tizanidine 2mg 80425 0436 03)

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 01)

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 02)

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 03)

This information appears to show the improvement in Ashworth score over time after administering different dosages of tizanidine and a placebo. The graph likely illustrates how the scores change in hours post-dose for 16mg tizanidine, 8mg tizanidine, and placebo.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 04)

This text discusses the improvement in Ashworth Score with Tizanidine at a mean dose of 26.8 mg over the course of a study, with specific points noted at the end of titration, end of maintenance, and the study endpoint. The Last Observation Carried Forward method was used for the endpoint analysis.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.